BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 20356845)

  • 1. Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression.
    Yori JL; Johnson E; Zhou G; Jain MK; Keri RA
    J Biol Chem; 2010 May; 285(22):16854-63. PubMed ID: 20356845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer.
    Lee HK; Lee DS; Park JC
    BMC Cancer; 2015 Mar; 15():113. PubMed ID: 25879941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Krüppel-Like Factor 4 Inhibits Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis by Down-Regulating Caveolin-1 Expression.
    Zhu Z; Yu Z; Wang J; Zhou L; Zhang J; Yao B; Dou J; Qiu Z; Huang C
    Cell Physiol Biochem; 2018; 46(1):238-252. PubMed ID: 29587259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer.
    Yori JL; Seachrist DD; Johnson E; Lozada KL; Abdul-Karim FW; Chodosh LA; Schiemann WP; Keri RA
    Neoplasia; 2011 Jul; 13(7):601-10. PubMed ID: 21750654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
    Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC
    Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between KLF4 and ZEB2/SIP1 in the regulation of E-cadherin expression.
    Koopmansch B; Berx G; Foidart JM; Gilles C; Winkler R
    Biochem Biophys Res Commun; 2013 Feb; 431(4):652-7. PubMed ID: 23376074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Krüppel-like factor 4 negatively regulates β-catenin expression and inhibits the proliferation, invasion and metastasis of gastric cancer.
    Zhang N; Zhang J; Shuai L; Zha L; He M; Huang Z; Wang Z
    Int J Oncol; 2012 Jun; 40(6):2038-48. PubMed ID: 22407433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion.
    Wang X; Zheng M; Liu G; Xia W; McKeown-Longo PJ; Hung MC; Zhao J
    Cancer Res; 2007 Aug; 67(15):7184-93. PubMed ID: 17671186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Krüppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression.
    Lin ZS; Chu HC; Yen YC; Lewis BC; Chen YW
    PLoS One; 2012; 7(8):e43593. PubMed ID: 22937066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
    Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma.
    Li H; Wang J; Xiao W; Xia D; Lang B; Yu G; Guo X; Guan W; Wang Z; Hu Z; Liu J; Ye Z; Xu H
    Carcinogenesis; 2013 Oct; 34(10):2262-70. PubMed ID: 23722653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1.
    Huang W; Zhang Y; Varambally S; Chinnaiyan AM; Banerjee M; Merajver SD; Kleer CG
    Am J Pathol; 2008 Apr; 172(4):893-904. PubMed ID: 18321996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.
    Arima Y; Inoue Y; Shibata T; Hayashi H; Nagano O; Saya H; Taya Y
    Cancer Res; 2008 Jul; 68(13):5104-12. PubMed ID: 18593909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Krüppel-like factor 4 is involved in cell scattering induced by hepatocyte growth factor.
    Lai JK; Wu HC; Shen YC; Hsieh HY; Yang SY; Chang CC
    J Cell Sci; 2012 Oct; 125(Pt 20):4853-64. PubMed ID: 22854048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Kruppel-like KLF4 transcription factor, a novel regulator of urokinase receptor expression, drives synthesis of this binding site in colonic crypt luminal surface epithelial cells.
    Wang H; Yang L; Jamaluddin MS; Boyd DD
    J Biol Chem; 2004 May; 279(21):22674-83. PubMed ID: 15031282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion.
    Yu F; Li J; Chen H; Fu J; Ray S; Huang S; Zheng H; Ai W
    Oncogene; 2011 May; 30(18):2161-72. PubMed ID: 21242971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor.
    DiFeo A; Narla G; Camacho-Vanegas O; Nishio H; Rose SL; Buller RE; Friedman SL; Walsh MJ; Martignetti JA
    Oncogene; 2006 Sep; 25(44):6026-31. PubMed ID: 16702959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA TCONS_00068220 Promotes Breast Cancer Progression by Regulating Epithelial-Mesenchymal Transition Marker E-Cadherin.
    Liu X; Tian X
    Med Sci Monit; 2021 Mar; 27():e929832. PubMed ID: 33716295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.
    Shah P; Gau Y; Sabnis G
    Breast Cancer Res Treat; 2014 Jan; 143(1):99-111. PubMed ID: 24305977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.